Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Immunogenicity and Safety of Different Vaccination Interval of Inactivated Hepatitis A Vaccine in People Aged 18-50 Years, a Phase IV Clinical Trial

NCT06058416 is registered in ClinicalTrials.gov with Sinovac Biotech Co., Ltd as lead sponsor.

NCT NCT06058416
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06058416 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Immunogenicity and Safety of Different Vaccination Interval of Inactivated Hepatitis A Vaccine in People Aged 18-50 Years, a Phase IV Clinical Trial
Lead sponsor
Sinovac Biotech Co., Ltd
Phase
Phase 4
Overall status
Active, not recruiting
Start date
October 24, 2023
Completion date
December 31, 2029
Enrollment
1,092 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis a